Reuters Analysis Finds Average Launch Price For Drugs Approved By FDA in 2025… Read More
Report Finds List Prices for Best-Selling Medicare Part D Prescription Drugs… Read More
Analysis Demonstrates Tremendous Cost of Anti-Competitive Tactics Like Patent… Read More
New Report Details Impact of Big Pharma Giant’s Strategy to Maintain… Read More
New Report Demonstrates How Brand Name Drug Companies Wield Litigation Around… Read More
Big Pharma Sets Out-of-Control Launch Prices, Hikes Prices Outpacing… Read More
U.S. Prescription Drug Spending Climbs as Big Pharma Sets New Records for… Read More
Making Health Care Affordable for the American People Means Holding Big Pharma… Read More
New Research Shows Drugmakers Increasingly Rely on Patents Disconnected from… Read More
AARP Analysis Highlights Substantial Cost Savings for Nearly Nine Million… Read More
Big Pharma Undercut Its Own False Claims About Innovation in 2025 With each… Read More
Exploring Big Pharma’s Egregious Abuse of the Patent System Designed to… Read More